Other methods/technologies:
The Drug Metabolism Research Laboratory (LEMM) has a high expertise in mass spectrometry based metabolomic, lipidomic and glycomic technologies for biomarker discovery in the field of clinical sciences. We also develop analytical methods for absolute quantification of metabolites and proteins that could be applied to biomarker validation purpose. Our laboratory is equipped with 10 mass spectrometers and works in collaboration with academics and industrial partners. To meet quality control requirements, we are GLP accredited since 1997 and ISO 9001 certified since December 2014.